Financings in Brief: ESC Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
ESC Medical Systems: Firm completes a $115 mil. placement of 6% convertible subordinated notes due 2002. Proceeds from the offering -- which included exercise of a $15 mil. over-allotment option -- will be used for working capital and general corporate purposes, including possible acquisitions. The notes are convertible into the company's ordinary shares at a conversion price equal to $46.55 per share, the Yokneam, Israel-based dermatologic laser firm states ("The Gray Sheet" Sept. 15, p. 21)...
You may also be interested in...
Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
Medtech Industry Favorite Wins Seat On Powerful House E&C Committee
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.
Source: 3 Former Obama US CMS Officials Being Considered To Lead Biden’s Medicare Agency
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: